Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150462
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2005-09-06
Brief Title:
Safety Study of the Proteasome Inhibitor PR-171 Carfilzomib for Injection in Patients With Hematological Malignancies
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
September 6 2005
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-12-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-28
Last Update Post Date:
2017-05-02
Last Update Post Date Type:
ACTUAL